Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability | Zendy

Felipe Fregni | Zendy; Brui | Zendy; Renério Fráguas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability

Author(s) -

Felipe Fregni,

Brui,

Renério Fráguas

Publication year - 2009

Publication title -

therapeutics and clinical risk management

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.719

H-Index - 55

eISSN - 1178-203X

pISSN - 1176-6336

DOI - 10.2147/tcrm.s5751

Subject(s) - tolerability , medicine , neurostimulation , antidepressant , discontinuation , sertraline , clinical trial , intensive care medicine , psychiatry , adverse effect , anxiety , stimulation

Use of antidepressants is the gold standard therapy for major depression. However, despite the large number of commercially available antidepressant drugs there are several differences among them in efficacy, tolerability, and cost-effectiveness. In addition the optimal augmentation strategy is still not clear when dealing with treatment-resistant depression, a condition that affects 15% to 40% of depressed patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research